AlphaCentric Advisors »

Rhythm Pharmaceuticals shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $541k 5.1k 107.04

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invitation Homes (INVH)
Ishares Tr Mbs Etf (MBB)
Euronet Worldwide (EEFT)
Vertex Pharmaceuticals Incorporated (VRTX)
Astrazeneca Sponsored Adr
Alpine Income Ppty Tr (PINE)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Ionis Pharmaceuticals (IONS)
Stereotaxis Com New (STXS)
Incyte Corporation (INCY)
Insmed Com Par $.01 (INSM)
AMREP Corporation (AXR)
Argenx Se Sponsored Adr (ARGX)

View all positions for AlphaCentric Advisors

Top funds holding Rhythm Pharmaceuticals

Perceptive Advisors
BlackRock
Vanguard Group
RA Capital Management
Baker Bros. Advisors
PRIMECAP Management Company
NEA Management Company
State Street Corporation
FMR
Goldman Sachs Group
Federated Investors
Driehaus Capital Management
Geode Capital Management
Westfield Capital Management Company
Jpmorgan Chase & Co

View all funds holding Rhythm Pharmaceuticals